SCHEMBL6593708

SCHEMBL6593708

COC(=O)c1scc(COC(C)=O)c1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.38
F2 P00734 1/20 0.37
KMT2A Q03164 6/20 0.36
MEN1 O00255 3/20 0.36
KDM4E B2RXH2 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP3A4 P08684 1/20 0.36
HTR1A P08908 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
POLB P06746 1/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 1/20 0.35
TSHR P16473 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
MAPK1 P28482 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27595508 0.86 F10 (0.42) F10F2KMT2AMEN1KDM4E
SCHEMBL6591889 0.81 KMT2A (0.39) F10KMT2AMEN1KDM4ECYP1A2
SCHEMBL6587977 0.81 KMT2A (0.39) F10KMT2AMEN1KDM4ECYP1A2
SCHEMBL3306728 0.80 KMT2A (0.41) F10KMT2AMEN1KDM4ECYP1A2
SCHEMBL6594409 0.79 KDM4E (0.40) F10F2KMT2AKDM4ECYP1A2
SCHEMBL27472593 0.77 KMT2A (0.40) F10KMT2AMEN1KDM4ECYP1A2
SCHEMBL6595088 0.77 KDM4E (0.40) F10KMT2AMEN1KDM4ECYP1A2
SCHEMBL6587446 0.76 CYP2A6 (0.37) F10KMT2AMEN1KDM4ECYP1A2
SCHEMBL4680589 0.75 KMT2A (0.50) KMT2AMEN1KDM4ECYP1A2MAPT
SCHEMBL4837886 0.74 F2 (0.39) F10F2KMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1143855-C I (ortho)-anthranilamide derivatives as anti-coagulants ���ֹɷݹ�˾ 2004-03-31 CN disclosed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
CN-1282329-A I (ortho)-anthranilamide derivatives as anti-coagulants SCHERING AG (DE) 2001-01-31 CN disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed
EP-1040108-A1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AKTIENGESELLSCHAFT (DE) 2000-10-04 EP disclosed
WO-1999032477-A1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AKTIENGESELLSCHAFT (DE) 1999-07-01 WO disclosed